Solventum (SOLV) Research & Development (2023 - 2026)

Solventum (SOLV) has 4 years of Research & Development data on file, last reported at $189.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 2.07% year-over-year to $189.0 million; the trailing twelve-month figure through Mar 2026 stood at $736.0 million (down 4.79% YoY), and the FY2025 full-year result was $739.0 million, down 4.65% from the prior year.
• Research & Development for Q1 2026 stood at $189.0 million, up from $175.0 million in the prior quarter.
• Across five years, Research & Development topped out at $199.0 million in Q4 2024 and bottomed at $175.0 million in Q4 2025.
• The 4-year median for Research & Development is $190.0 million (2023), against an average of $189.4 million.
• The widest annual swing landed in 2024, when Research & Development climbed 5.0%; it then declined 12.06% in 2025.
• A 4-year view of Research & Development shows it stood at $190.0 million in 2023, then rose by 4.74% to $199.0 million in 2024, then slipped by 12.06% to $175.0 million in 2025, then climbed by 8.0% to $189.0 million in 2026.
• The last three Research & Development figures came in at $189.0 million (Q1 2026), $175.0 million (Q4 2025), and $183.0 million (Q3 2025), per Business Quant data.

Peer Comparison